| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |